1. Home
  2. CAR vs RYTM Comparison

CAR vs RYTM Comparison

Compare CAR & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

HOLD

Current Price

$148.35

Market Cap

3.4B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$76.25

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAR
RYTM
Founded
1946
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
6.4B
IPO Year
1998
2017

Fundamental Metrics

Financial Performance
Metric
CAR
RYTM
Price
$148.35
$76.25
Analyst Decision
Hold
Strong Buy
Analyst Count
7
14
Target Price
$127.57
$131.14
AVG Volume (30 Days)
629.1K
914.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
50.71
28.34
EPS
N/A
N/A
Revenue
$11,652,000,000.00
N/A
Revenue This Year
$2.17
$55.17
Revenue Next Year
$1.78
$95.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$62.17
$45.91
52 Week High
$212.81
$122.20

Technical Indicators

Market Signals
Indicator
CAR
RYTM
Relative Strength Index (RSI) 81.74 31.50
Support Level $147.93 $60.71
Resistance Level $163.57 $98.37
Average True Range (ATR) 8.29 5.71
MACD 5.91 -0.74
Stochastic Oscillator 99.39 0.08

Price Performance

Historical Comparison
CAR
RYTM

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: